RS51169B - Kamptotecini konjugirani na položaju 7 sa cikličnim peptidima kao citostatička sredstva - Google Patents

Kamptotecini konjugirani na položaju 7 sa cikličnim peptidima kao citostatička sredstva

Info

Publication number
RS51169B
RS51169B RSP-2009/0152A RSP20090152A RS51169B RS 51169 B RS51169 B RS 51169B RS P20090152 A RSP20090152 A RS P20090152A RS 51169 B RS51169 B RS 51169B
Authority
RS
Serbia
Prior art keywords
group
branched
linear
alkylene
alkyl
Prior art date
Application number
RSP-2009/0152A
Other languages
English (en)
Inventor
Sergio Penco
Lucio Merlini
Franco Zunino
Loredana Vesci
Hong Ni Ming
Claudio Pisano
Alma Dal Pozzo
Giuseppe Giannini
Maria Ornella Tinti
Domenico Alloatti
Sabrina Dallavalle
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Istituto Nazionale Per Lo Studio E La Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A., Istituto Nazionale Per Lo Studio E La Cura Dei Tumori filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of RS51169B publication Critical patent/RS51169B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RSP-2009/0152A 2004-05-13 2005-05-04 Kamptotecini konjugirani na položaju 7 sa cikličnim peptidima kao citostatička sredstva RS51169B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000240A ITRM20040240A1 (it) 2004-05-13 2004-05-13 Camptotecine coniugate in posizione 7 con antagonisti delle integrine.
PCT/IT2005/000260 WO2005111063A1 (en) 2004-05-13 2005-05-04 Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents

Publications (1)

Publication Number Publication Date
RS51169B true RS51169B (sr) 2010-10-31

Family

ID=34968014

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2009/0152A RS51169B (sr) 2004-05-13 2005-05-04 Kamptotecini konjugirani na položaju 7 sa cikličnim peptidima kao citostatička sredstva

Country Status (23)

Country Link
US (1) US7705012B2 (sr)
EP (1) EP1753776B1 (sr)
JP (1) JP4805917B2 (sr)
KR (1) KR101145815B1 (sr)
CN (1) CN1953989B (sr)
AR (1) AR048949A1 (sr)
AT (1) ATE420891T1 (sr)
AU (1) AU2005243417B2 (sr)
BR (1) BRPI0510983A (sr)
CA (1) CA2563708A1 (sr)
CY (1) CY1108985T1 (sr)
DE (1) DE602005012390D1 (sr)
DK (1) DK1753776T3 (sr)
ES (1) ES2321114T3 (sr)
HR (1) HRP20090146T3 (sr)
IT (1) ITRM20040240A1 (sr)
MX (1) MXPA06012884A (sr)
PL (1) PL1753776T3 (sr)
PT (1) PT1753776E (sr)
RS (1) RS51169B (sr)
SI (1) SI1753776T1 (sr)
TW (1) TWI352703B (sr)
WO (1) WO2005111063A1 (sr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040239A1 (it) * 2004-05-13 2004-08-13 Sigma Tau Ind Farmaceuti Derivati ciclopeptidici ad attivita' antintegrine.
EP2120948A1 (en) * 2007-02-13 2009-11-25 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives
TW201004647A (en) * 2008-05-20 2010-02-01 Sigma Tau Ind Farmaceuti Novel dual targeting antitumoural conjugates
WO2011002852A2 (en) * 2009-06-30 2011-01-06 The Regents Of The University Of Michigan Pro-drug complexes and related methods of use
US9073974B2 (en) 2009-12-21 2015-07-07 The Regents Of The University Of California RGD-containing cyclic peptides
US8685928B2 (en) 2010-02-12 2014-04-01 Dana-Farber Cancer Institute, Inc. Antagonists of MUC1
WO2013026015A1 (en) 2011-08-18 2013-02-21 Dana-Farber Cancer Institute, Inc. Muc1 ligand traps for use in treating cancers
CN102516258B (zh) * 2011-11-11 2014-06-25 正大天晴药业集团股份有限公司 水溶性维生素e衍生物修饰的脂溶性抗癌药物化合物和制剂、该化合物的制备方法及应用
US9044421B2 (en) 2012-03-28 2015-06-02 Genus Oncology, Llc Treating MUC1-expressing cancers with combination therapies
EP3310787B9 (en) 2015-06-18 2020-07-01 Ramot at Tel-Aviv University Ltd. Taggable heteroaromatic drugs and conjugates thereof
US10494403B2 (en) * 2018-03-06 2019-12-03 Ciphore Biomed Technology Limited Company Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE136898T1 (de) * 1991-10-29 1996-05-15 Glaxo Wellcome Inc Wasserlösliche camptothecinderivate
US5646159A (en) * 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds
CA2192725C (en) 1995-12-28 2004-04-20 Kenji Tsujihara Camptothecin derivatives
JP4311765B2 (ja) * 1997-02-14 2009-08-12 バイオニューメリック・ファーマスーティカルズ，インコーポレイテッド 高親油性カンプトテシン誘導体
DE19815812A1 (de) * 1998-04-08 1999-10-14 Bayer Ag Modifizierte Cytostatika
EP1044977B1 (en) 1999-03-09 2002-05-02 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Camptothecin derivatives having antitumor activity
CA2383981A1 (en) * 1999-09-08 2001-03-15 Bayer Aktiengesellschaft Integrin-mediated drug targeting
AU2002220593A1 (en) * 2000-10-06 2002-04-15 Novartis Ag Targeting molecules for adenoviral vectors
AU2002314861A1 (en) * 2001-05-30 2002-12-09 Targesome, Inc. Targeted multivalent macromolecules

Also Published As

Publication number Publication date
EP1753776B1 (en) 2009-01-14
DE602005012390D1 (de) 2009-03-05
CN1953989A (zh) 2007-04-25
ATE420891T1 (de) 2009-01-15
DK1753776T3 (da) 2009-05-11
PT1753776E (pt) 2009-03-05
AU2005243417A2 (en) 2005-11-24
US20080033003A1 (en) 2008-02-07
AU2005243417B2 (en) 2011-07-07
TW200606165A (en) 2006-02-16
PL1753776T3 (pl) 2009-06-30
ITRM20040240A1 (it) 2004-08-13
MXPA06012884A (es) 2007-02-15
BRPI0510983A (pt) 2007-12-04
JP2008504235A (ja) 2008-02-14
JP4805917B2 (ja) 2011-11-02
ES2321114T3 (es) 2009-06-02
AR048949A1 (es) 2006-06-14
TWI352703B (en) 2011-11-21
KR101145815B1 (ko) 2012-05-16
WO2005111063A1 (en) 2005-11-24
AU2005243417A1 (en) 2005-11-24
SI1753776T1 (sl) 2009-06-30
HRP20090146T3 (en) 2009-05-31
CA2563708A1 (en) 2005-11-24
EP1753776A1 (en) 2007-02-21
US7705012B2 (en) 2010-04-27
CY1108985T1 (el) 2014-07-02
CN1953989B (zh) 2012-10-10
KR20070012530A (ko) 2007-01-25

Similar Documents

Publication Publication Date Title
RS51169B (sr) Kamptotecini konjugirani na položaju 7 sa cikličnim peptidima kao citostatička sredstva
CO5251381A1 (es) Derivados de adamantano, un proceso para su preparacion y composiciones farmaceuticas que los contienen
RS53372B (sr) Metodi za tretiranje upalnih bolesti
TW200719919A (en) Hair cleansing composition
BR0114994A (pt) Composição de vacina
ES2647774T3 (es) Tioéteres, métodos para su preparación, y composiciones que incluyen dichos tioéteres
RS51852B (sr) Modifikovani peptidi kao terapeutski agensi
BRPI0520658A2 (pt) composto, composição curável por energia e processo para sua preparação
BR112016009207A8 (pt) compostos de prostaciclina
KR870000916A (ko) 샴푸조성물
DE60311995D1 (de) Neue purine derivate
DE69110136D1 (de) Kaffeinsaure-derivate,oraposid,ihre kosmetische oder pharmazeutische zusammensetzungen,insbesondere mit dermatologischer wirkung.
BR112016014595A8 (pt) material à base de sólido para uso tópico sobre a pele,composição aquosa e método de produção do mesmo.
JP2008504235A5 (sr)
LV5794A4 (lv) Nonapeptidi ar bombezina antagonistu ipasibam
HRP20090244T2 (en) Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1
CO5261527A1 (es) Eteres del acido benzoico de oxazolidinonas que tienen un substituyente hidroxiacetilpiperazina
KR910018404A (ko) 혈소판-응집 억제제
RU2008129099A (ru) Композиции для лечения волос
KR910000178A (ko) 관절염의 치료
RU2016134357A (ru) Конъюгаты фактора viii
ES2280992T3 (es) Composicion de un acelerador para acelerar el fraguado y/o el endurecimiento de una composicion de cemento.
KR910004665A (ko) 사이클릭 뉴로키닌 a 길항제
AR024463A1 (es) Agonistas de somatostatina
AR049337A1 (es) 7-t-butoxiiminometilcamptotecina conjugada en la posicion 20 con antagonistas de la integrina